It would be interesting for how they negotiate contracts with telehealth. $10 per use is great for diagnosing pneumonia. And ongoing asthma maintenance. But just imagine if the app were eventually able to diagnose TB or lung cancer. I would have thought that would be worth more than $10.
Australia-China Biotech Invest 2017, page-9
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online